As of 3:59pm ET
| -0.20 / -1.65%|
The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a +121.76% increase from the last price of 11.95.
The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.